Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.As of 25 May 2026, MAKERS LABORATORIES LTD. share price is ₹163.40. The stock opened at ₹164.25, compared to its previous close of ₹164.25. During today's trading session, MAKERS LABORATORIES LTD. share price moved in the range of ₹158.60 to ₹168.75, with an average price of ₹163.68 for the day. Looking at its last 52-week, the stock has touched a low of ₹158.60 and a high of ₹168.75.
The market capitalization of MAKERS LABORATORIES LTD. is ₹97 Crs, with a P/E ratio of 16.5 and a dividend yield of 0.00%.